The Track Record Trust Problem: Why Most Backtests Don't Survive Due Diligence

Imagine two managers pitch the same allocator. The first shows a backtest with a 4.0 Sharpe and an equity curve that climbs like a staircase. The second shows a 2.0 Sharpe with a couple of real drawdowns. Which one raises the money?

If you said the first, you've never sat on the other side of the table. The experienced allocator's reaction to the 4.0 isn't excitement — it's suspicion. Because they know something most aspiring managers learn too late: a beautiful backtest is the easiest thing in finance to manufacture, and therefore the least trustworthy. The staircase doesn't make them want to invest. It makes them want to find out what's wrong with it.

This is the track record trust problem, and understanding it is the difference between a deck that raises capital and one that gets a polite no.

Why allocators distrust great backtests

Anyone who has spent time near systematic trading has seen — or built — a backtest that looked incredible and traded terribly. The ways to inadvertently inflate a backtest are numerous, subtle, and mostly invisible in the final chart:

• Look-ahead bias — the strategy quietly used information it couldn't have had at the time. The single most common backtest lie, and almost never deliberate.
• Survivorship and selection — you tested the parameters that happened to work and quietly dropped the ones that didn't, fitting the strategy to the past.
• Ignored costs — no slippage, no fees, and in crypto, no funding — so the paper strategy keeps money the real one would have paid away.
• Thin or gappy data — a confident number computed over a window that was half holes, patched over invisibly.
• Flattering math — annualizing on the wrong time base, computing risk metrics the convenient way instead of the textbook way.

Every one of these makes the curve prettier. None of them makes the strategy better. And the allocator's entire job is to tell the difference — so the prettier the curve, the harder they look for which of these is hiding inside it.

Due diligence is an adversarial recomputation

Here's what actually happens when a serious allocator evaluates your track record: they try to break it. They'll ask how you handled costs. They'll ask about your data coverage. They'll recompute your Sharpe and your annualized return by hand and see if they match. They'll probe for look-ahead by asking exactly what information the strategy used and when it became available. They'll want to know what happens to the result when they nudge a parameter.

This is not hostility — it's the job. An allocator who doesn't stress-test your numbers is one who'll lose their investors' money on someone else's. So the question isn't whether your backtest will be scrutinized. It's whether it will survive the scrutiny.

And most don't. Not because the managers were dishonest, but because the tools they used made the inflating mistakes easy and the catching of them hard.

Survivable numbers come from honest infrastructure

The managers whose track records survive due diligence almost always have one thing in common: their numbers were honest before anyone looked, because the infrastructure that produced them was built to be honest.

That means a backtester where look-ahead is structurally impossible, not merely discouraged — where every signal is aligned to the moment it was actually knowable, by construction. It means realistic costs baked in: slippage, fees, and funding modeled the way the market actually charges them. It means metrics computed the textbook way, so when the allocator recomputes, the numbers reconcile instead of diverging. It means honesty about data gaps, surfaced alongside every result, so a thin window is disclosed rather than hidden.

When your infrastructure does all of that, something powerful happens in the meeting: you can answer the hard questions. "How did you handle funding?" — modeled per bar, per venue, here's the breakdown. "What was your data coverage?" — here's the report, including the thin patches. "Can I recompute your Sharpe?" — please do, it'll match. Every confident, specific, verifiable answer builds the thing you're actually selling, which was never the Sharpe ratio. It was your credibility.

The number isn't the asset — trust is

The hardest lesson in fundraising is that your backtest's job is not to be impressive. Its job is to be believable. A 2.0 Sharpe an allocator can verify, stress-test, and trust is worth infinitely more than a 4.0 they suspect and can't break, because capital follows conviction and conviction follows verification.

This reframes what good infrastructure is even for. It's tempting to want tools that make your numbers look as good as possible. You want the opposite. You want tools that make your numbers as defensible as possible — that produce a result you can stand behind in an adversarial room and watch survive every attempt to break it.

The managers who raise capital aren't the ones who learned to make backtests beautiful. They're the ones who learned to make them true, and then let the allocator confirm it. Be the second manager. The honest 2.0 is the one that gets funded.

---

Produce track records that survive due diligence — no look-ahead, real costs, textbook metrics, honest data reporting. See how →